DIAGNOSTIC_TEST · Unmapped registry intervention
CellSearch Circulating Tumor Cells
Find medicine records ·
Find other trials using this name
Clinical trial
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
NCT05662345
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Breast Cancerunresolved
Interventions
CellSearch Circulating Tumor CellsDIAGNOSTIC_TEST
Sponsors & collaborators
Menarini Silicon Biosystems, INClead sponsor
Medex15collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05662345 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.